4-nitrophenyl-beta-D-mannopyranoside: see also record for (alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 161880 |
| CHEMBL ID | 4462691 |
| SCHEMBL ID | 149793 |
| MeSH ID | M0110258 |
| Synonym |
|---|
| 4-nitrophenyl d-mannopyranoside |
| 4-nitrophenyl beta-d-mannopyranoside |
| 4-nitrophenyl beta-d-mannopyranoside, >=98% |
| (2s,3r,4s,5s)-2-(4-nitrophenoxy)-tetrahydro-6-(hydroxymethyl)-2h-pyran-3,4,5-triol |
| 4-nitrophenyl-beta-d-mannopyranoside |
| 35599-02-1 |
| (2r,3s,4s,5s,6s)-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxane-3,4,5-triol |
| p-nitrophenyl-beta-d-mannoside |
| p-nitrophenyl beta-d-mannopyranoside |
| einecs 252-633-9 |
| para-nitrophenyl-beta-d-mannopyranoside |
| AKOS016015680 |
| AKOS015897098 |
| paranitrophenyl mannopyranoside |
| SCHEMBL149793 |
| p-nitrophenyl-beta-d-mannopyranoside |
| MBE , |
| mfcd00067650 |
| 4-nitrophenyl i(2)-d-mannopyranoside |
| CHEMBL4462691 |
| STL555800 |
| Q27463058 |
| (2r,3s,4s,5s,6s)-2-(hydroxymethyl)-6-(4-nitrophenoxy)tetrahydro-2h-pyran-3,4,5-triol |
| b-d-mannopyranoside, 4-nitrophenyl |
| DTXSID001298822 |
| 4-nitrophenyl beta -d-mannopyranoside |
| wurcs=2.0/1,1,0/[a1122h-1b_1-5_1*o(c^ec^zc^ec^ec^zc^e$3)/6no/9=o]/1/ |
| gtpl12453 |
| (4-nitrophenyl) d-manno-hexopyranoside |
| Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| detection of chemical stimulus involved in sensory perception of bitter taste | Taste receptor type 2 member 16 | Homo sapiens (human) |
| G protein-coupled receptor signaling pathway | Taste receptor type 2 member 16 | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| G protein-coupled receptor activity | Taste receptor type 2 member 16 | Homo sapiens (human) |
| protein binding | Taste receptor type 2 member 16 | Homo sapiens (human) |
| bitter taste receptor activity | Taste receptor type 2 member 16 | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| endoplasmic reticulum | Taste receptor type 2 member 16 | Homo sapiens (human) |
| trans-Golgi network | Taste receptor type 2 member 16 | Homo sapiens (human) |
| plasma membrane | Taste receptor type 2 member 16 | Homo sapiens (human) |
| external side of plasma membrane | Taste receptor type 2 member 16 | Homo sapiens (human) |
| membrane | Taste receptor type 2 member 16 | Homo sapiens (human) |
| membrane | Taste receptor type 2 member 16 | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.31) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||